2005 - Study on absorption and tissue distribution, mechanism and regulation of xenobiotics
Show all
Papers (10):
Oda K, Mori N, Okumi M, Furusawa M, Ishiguro M, Inoue K, Shuto S, Unagami K, Ishida H, Tanabe K, et al. Uptake and metabolism of mizoribine, an immunosuppressant, in L5178Y-R mouse lymphoma cells in vitro and peripheral blood mononuclear cells of rats and kidney transplant recipients in vivo. Drug Metab Pharmacokinet. 2018. 33. 5. 232-239
K.Oda, T.Mumakoshi, R/Kasai, T.Murakami. Biopharmaceutical properties of tubeimoside-1: a cytotoxic amphipathic cyclic bisdesmoside. Int. J. Clin. Phamacol. Pharmacother. 2017. 2. 126-131
Teno N, Iguchi Y, Yamashita Y, Mori N, Une M, Nishimaki-Mogami T, Gohda K. Discovery and optimization of benzimidazole derivatives as a novel chemotype of farnesoid X receptor (FXR) antagonists. Bioorg Med Chem. 2017. 25. 6. 1787-1794
Aoi Matsushima, Keisuke Oda, Nobuhiro Mori, Teruo Murakami. Modulation of multidrug resistance-associated proteins function in erythrocytes in glycerol-induced acute renal failure rats. JOURNAL OF PHARMACY AND PHARMACOLOGY. 2017. 69. 2. 172-181
T. Yokooji, Y. Kameda, M. Utsumi, N. Mori, T. Murakami. Interaction of hydrophobic components in female urine before and after childbirth with P-glycoprotein in vitro. PHARMAZIE. 2014. 69. 6. 430-436
Characterization of concentrative nucleoside transporter-mediated intestinal absorption of mizoribine in rats
(8th International ISSX Meeting 2007)
Stereoisomers of N-substituted soft anticholinergics and their zwitterionic metabolite based on glycopyrrolate-1. Pharmacological evaluation
(6th Retrometabolism Based Drug Design and Targeting Conference 2007)